The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.
During COVID-19 peaks, some hospitals that experienced high patient volumes scrambled to meet the increased demand for renal replacement therapy (RRT). With nearly one-third of the sickest COVID patients requiring RRT, the pandemic’s early weeks saw supply shortages in some locales, stretching skilled personnel to the breaking point.
The choices some health systems made then could also signal a shift in the way RRT is delivered in the...
European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.
The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.
Ultrahuman seeks to “create an environment that aligns with our bodies" by linking environmental parameters collected by Ultrahuman Home to health physiology, measured by the Ultrahuman Ring Air.
The rallying cry to start as early as possible has become increasingly common in the world of medical device development. Innovation expert Dr. Stuart Grant challenges this conventional wisdom, asking: Is "sooner" truly better, or is there a smarter path to market for your medical device?
